Integra LifeSciences to Showcase Leadership at Major Conference
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a distinguished medical technology innovator, made a significant announcement regarding its participation in a prominent healthcare event. The company’s chief executive officer, Mojdeh Poul, alongside chief financial officer, Lea Knight, will be presenting at the Citi 2025 Global Healthcare Conference. This event is scheduled for December 3, 2025, at 10:30 a.m. ET, and represents a great opportunity for the company to share its latest advancements and expertise.
Live Webcast Information
For those unable to attend in person, a live webcast of the presentation will be accessible via the Integra LifeSciences investor relations website. This session will allow stakeholders and investors to gain insight into the company’s innovative strategies and future direction. It's a fantastic chance to glimpse how Integra is poised to impact the healthcare industry positively.
About Integra LifeSciences
Integra LifeSciences is driven by a fundamental purpose: to restore patients' lives through innovation. The company focuses on advancing treatment paths that improve patient outcomes while setting cutting-edge standards in surgical, neurologic, and regenerative care. With a robust portfolio encompassing leadership brands, Integra strives to deliver high-quality solutions that cater to diverse medical needs.
Commitment to Innovation
One of the core strengths of Integra LifeSciences lies in its unwavering commitment to innovation. The company continuously seeks to develop new technologies that enhance patient care and surgical outcomes. By investing in research and development, Integra aims to remain at the forefront of the medical technology sector, constantly evolving to meet the needs of healthcare providers and patients alike.
Investor Relations and Media Contacts
For inquiries related to investments and corporate updates, Chris Ward, the contact for investor relations, is available at (609) 772-7736 or via email at chris.ward@integralife.com. On the media side, Laurene Isip serves as the primary media contact and can be reached at (609) 208-8121 or laurene.isip@integralife.com. Both representatives are committed to providing comprehensive support and answers to stakeholder queries.
Looking Ahead: Future Developments
The future looks bright for Integra LifeSciences as it prepares not only for the upcoming conference but also for a series of product releases and innovations that are expected to make waves in the industry. With a focus on enhancing the quality of life for patients around the world, Integra is set to expand its influence within the medical technology landscape.
Frequently Asked Questions
1. What is the significance of the Citi 2025 Global Healthcare Conference?
The conference serves as an essential platform for healthcare leaders to share insights, innovations, and strategies impacting the medical sector.
2. Who are the featured speakers from Integra LifeSciences?
Mojdeh Poul (CEO) and Lea Knight (CFO) will represent the company at the conference.
3. How can I access the live presentation?
The presentation will be available through a live webcast on Integra LifeSciences' investor relations website.
4. What are Integra LifeSciences' core commitments?
Integra is dedicated to restoring patients' lives through innovative medical technologies and improving patient outcomes.
5. Who can I contact for more information?
For investor queries, reach out to Chris Ward, and for media inquiries, contact Laurene Isip at Integra LifeSciences.
